TR10 (Tirzepatide) is a dual receptor agonist research peptide used for metabolic signaling, receptor action mechanisms, and peptide pharmacology studies via GLP-1 and GIP receptor-related pathways.
Tirzepatide TR10 is a synthetic modified peptide research compound composed of 39 amino acids, belonging to the GLP-1/GIP dual receptor agonist class. Its research value is enhanced through structural optimization and fatty acid modification, primarily for exploring the incretin receptor signaling pathway, metabolic regulatory mechanisms, and the development of novel multi-target peptide molecules. The product is typically supplied as a white to off-white lyophilized powder, and quality analysis is performed by HPLC purity determination and LC-MS identification.
Tirzepatide TR10 is primarily used in metabolic biology, receptor signaling research, and peptide pharmacology, including studies on the activation mechanism of the GLP-1R/GIPR dual receptor, cell signal transduction analysis, glucose metabolism, energy balance, receptor binding experiments, and the development of novel metabolic regulatory peptides. Researchers utilize this molecule to explore the synergistic effects of multiple receptors and the regulatory mechanisms of related metabolic pathways.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Retatrutide (RT10) is a synthetic peptide research compound designed as a triple...
Retatrutide (RT20) is a novel synthetic modified peptide, with the research code...
Retatrutide RT30 is a 30mg research-grade peptide product of Retatrutide (LY3437...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.